Autopsy report · NCT04158349

Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“PI Decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 5 months before it started.
Ran for about 2 months before it stopped.
1 participant enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: University of Utah
Sponsor type: University, hospital or other
Conditions: Colorectal Cancer; Appendiceal Cancer; Peritoneal Carcinoma
Interventions: Oxaliplatin; mFOLFIRI
Participants: 1
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.